Indicator Gauge Icon Legend
Legend Colors
Red is bad, green is good, blue is not statistically different/neutral.
Compared to Distribution
the value is in the best half of communities.
the value is in the 2nd worst quarter of communities.
the value is in the worst quarter of communities.
Compared to Target
meets target; 
does not meet target.
Compared to a Single Value
lower than the comparison value;
higher than the comparison value;
not statistically different from comparison value.
Trend
non-significant change over time; 
significant change over time; 
no change over time.
Compared to Prior Value
higher than the previous measurement period;
lower than the previous measurement period;
no statistically different change from previous measurement period.
Significantly better than the overall value
Significantly worse than the overall value
No significant difference with the overall value
No data on significance available
Colorectal Cancer Incidence Rate
Measurement Period: 2017-2021
This indicator is archived and is no longer being updated. Click to learn more
This indicator shows the age-adjusted incidence rate for colorectal cancer in cases per 100,000 population.
Why is this important?
According to the Centers for Disease Control and Prevention (CDC), colorectal cancer--cancer of the colon or rectum-- is one of the most commonly diagnosed cancers in the United States, and is the third leading cancer killer in the United States. The CDC estimates that if all adults aged 50 or older had regular screening tests for colon cancer, as many as 60% of the deaths from colorectal cancer could be prevented. Risks and benefits of using different screening methods, such as stool-based tests, sigmoidoscopies, and colonoscopies, vary. The US Preventive Service Task Forces recommends that screening begin at age 45 and continue until age 75; however, testing may need to begin earlier or be more frequent if colorectal cancer runs in the family, or if there is a previous diagnosis of inflammatory bowel disease. Speak with a doctor about when to begin screening and how often to be tested.
33.3
cases/ 100,000 population
Source:
National Cancer Institute
Measurement period: 2017-2021
Maintained by: Conduent Healthy Communities Institute
Last update: November 2024
Measurement period: 2017-2021
Maintained by: Conduent Healthy Communities Institute
Last update: November 2024
Compared to
Technical note: Use caution when comparing overlapping 5-year periods since much of the data in each estimate are the same.
More details:
*Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category.
Graph Selections
No significant difference with the overall value
Data Source
- National Cancer Institute
Maintained By: Conduent Healthy Communities Institute (Methodology)
Filed under: Health / Cancer, Health Outcomes